IJPDA fully complies with the latest UGC journal selection guidelines issued on February 11, 2025. Click here for more information.

Online ISSN: 2348-8948
All submissions must comply with the COPE guidelines for ethical publishing practices.
The journal strives to resolve all complaints as soon as possible. The procedures followed by the International Journal of Pharmaceutics and Drug Analysis Journal to handle and resolve complaints aim to be fair for authors filing complaints and for those being complained about.
Appeals against editorial decisions
In case an author does not accept an editorial decision, he/she should contact the Editor-in-Chief of the journal. After the appeal is made by the author, the Editor-in-Chief will review the manuscript, and peer reviewers' comments and reach a decision for accepting or rejecting the manuscript. If required, the Editor-in-Chief may send the manuscript to new referees for peer review. The Editor-in-Chief's decision is final in such cases. All submitted complaints will be acknowledged within two working days.
IJPDA fully complies with the latest UGC journal selection guidelines issued on February 11, 2025. Click here for more information.

Online ISSN: 2348-8948
All submissions must comply with the COPE guidelines for ethical publishing practices.